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Persons who are at risk for Huntington’s Disease (HD) can be tested for the HD gene expansion before symptom onset. People
with the gene expansion, but no clinical diagnosis, are in the prodromal phase of HD. This study explored quality of life (QOL)
in prodromal HD. Interviews about QOL, conducted with 9 prodromal HD participants and 6 companions, were transcribed.
Discourse was coded for emotional valence, content (e.g., coping, spirituality, interpersonal relationships, HD in others, and
employment), and time frame (e.g., current, past, and future). Respondents were more positive than negative about the present,
which was their major focus. The most common statements were about positive attitudes. Positive statements were made about
spirituality, and negative statements were made about HD in other people. Relationships, employment, and coping with HD
reﬂected both positivity and negativity. Participants and companions spoke of the future with diﬀerent concerns. Applicability of
ﬁndings to the clinical management of HD are discussed.
1.Introduction
Huntington’s disease (HD) is a neurodegenerative disorder
that causes a triad of cognitive, motor, and psychiatric
symptoms [1]. It aﬀects approximately 5–7 of every 100,000
personsworldwide[1].Itstrikespersonsintheprimeoftheir
lives, has an adverse impact on quality of life (QOL), and
causes untold disability and suﬀering in patients and their
loved ones [2–4]. Further, HD is the result of a defect in a
single gene. If a parent has the HD gene expansion, there is
a 50% chance that his/her biological children will inherit the
disorder. The presence of the HD gene expansion indicates
100% certainty of developing HD at some point in life, if the
individual does not die of another cause.
ThegeneresponsibleforHDwasidentiﬁedin1993;thus,
persons can be tested to determine if they are gene-expanded
(i.e., they have the HD gene expansion and will develop the
disorder at some point in their lives) or nonexpanded (i.e.,
they do not have the HD gene expansion and they never
will develop HD) [5]. It is this aspect of HD that makes
it so exceedingly rare. Persons can know for certain if they
will develop a neurodegenerative disease that, eventually,
will aﬀect control of their muscles, emotions, and thinking
abilities, a progressive disease for which there is no cure and
few eﬀective treatments.
Persons who test positive for the HD gene expansion
b u th a v em i l do rn oc u r r e n ts y m p t o m sa r es a i dt ob ei n
the prodromal phase of HD (in the past, persons who were
gene-positive for HD but who did not meet diagnostic
criteria for the disease were often said to be presymptomatic
for HD; now, more often, persons in this stage of the disease
are referred to as being in the prodromal phase of HD, in
recognition that persons can suﬀer symptoms of HD prior
to meeting full diagnostic criteria for the disorder). In the
current project, nine adults with prodromal HD and six
nonexpanded companions were interviewed about quality
of life (QOL) in prodromal HD. Results provide insight
into the psychological impact of knowing, in part, what the
future holds. Currently, psychological research on genetic
testing in prodromal HD focuses largely on decisions to
undergo testing [6, 7]a n dr e a c t i o n st ot e s tr e s u l t s[ 8, 9], but2 Neurology Research International
very little work has attended to QOL issues after testing is
completed and a positive result is obtained.
Reactions to test results, on average, suggest few long-
term adverse consequences [8, 9], and some individuals
beneﬁt from test results by improving their interpersonal
relationships,renewingtheirappreciationforlifeandexplor-
ing new directions (i.e., new careers) [10, 11]. Anxiety and
depression temporarily increase for gene carriers, but, within
ayear,psychologicalsymptomsreturntobaseline.Pessimism
about the future and more suicidal ideation may occur
[12, 13].
The current qualitative study adds to this line of work by
focusing on a relatively unexplored psychological dimension
of prodromal HD, namely, life quality. Measuring QOL is
an important and relatively unexplored way to understand
disease impact [14]. Given the lack of previous research
on QOL in prodromal HD, the goal of the current study
was to take an in-depth look at perceptions of QOL from
a small convenience sample of persons who carry the gene
expansion, as well as close companions.
2. Methods
2.1. Participants. Participants self-reported that they had
the gene expansion responsible for HD—conﬁrmed through
genetic testing—but were not currently diagnosed with the
disease. Nine persons with prodromal HD (4 male; M age =
38.4years,SD =6.7;allCaucasian)participated. Eachinvited
a spouse without the gene expansion or, in one case, ﬁanc´ et o
participate; six of the nine companions agreed to participate
(3 male) (unfortunately, demographic information was not
collected for the companions). Companions were only
enrolled in the study if the participants with the HD gene
expansion consented to their companions’ participation and
agreed to answer the same questions regarding themselves.
All participants were recruited through a research registry or
a monthly HD clinic at the University of Iowa Hospitals and
Clinics Huntington’s Disease Center of Excellence.
All interviews were conducted individually and not in
dyads. All participants provided informed consent, and the
study was approved by the Internal Review Board at UIHC
(200802793)andattheUniversityofMassachusetts,Amherst
(969), where data coding and analyses occurred; the study
was conducted in accordance with the ethical standards of
the 1964 Declaration of Helsinki.
2.2. Procedure. Methods for data acquisition and coding
were based largely on Hill and colleagues’ Consensual
QualitativeResearch(CQR)approach,whichisideallysuited
for the early stages of research on previously unexplored
topics [15]. Brieﬂy, this method involves collection of data
from small samples (e.g., Ns = 8–15) via open-ended
interview questions. Through an inductive and iterative
process, content themes in the data are identiﬁed and coded;
codes are veriﬁed by an auditor (uninvolved in the initial
coding). Teams of researchers work on the project, and their
multiple perspectives and diﬀerences of opinion stimulate
rich exploration of the data. Individual interviews are coded,
allowing for comparisons across participants.
In the current study, participants and companions were
interviewed separately about QOL in prodromal HD. The
interview questions were open ended (see the appendix)
and were designed to prompt interviewees to think about
QOL from a variety of diﬀerent perspectives and to give
m a x i m a lo p p o r t u n i t yf o rp e r s o n st ob ea b l et or e ﬂ e c to n
their thoughts and ideas and life quality in an unstructured
manner, without leading the participants to express certain
ideas. All questions were asked of participants unless a
participant spontaneously addressed an issue before being
asked. Interviews were conducted by a trained, advanced
graduate student (J. J. F. O’Rourke). The interviews lasted
for 30–60 minutes and were conducted in person or over the
telephone. Interviews were audio-recorded and transcribed
verbatim (excluding identifying information) by trained
research assistants (RAs).
A single interviewer poses advantages and disadvantages.
The advantage is that the interview is administered in
roughly the same manner to all persons. A disadvantage is
that idiosyncrasies or oversights that are particular to the
interviewer could unduly inﬂuence the data. We selected one
interviewer because he was an advanced graduate student in
counseling and neuropsychology and had extensive experi-
ence with HD and prodromal HD in clinical and research
contexts; another interviewer with the same expertise was
not available. R. E. Ready reviewed all interviews to ensure
quality.
2.2.1. Identiﬁcation of Thematic Content. All of the inter-
views were read by an initial team of three RAs, and,
through an iterative process, common themes in the data
were identiﬁed; the interviewer (J. J. F. O’Rourke) was
not involved in this process to minimize bias in the
analysis. Identiﬁcation of prevalent content themes involved
systematic thematic analysis by individuals, discussion in
group meetings, and consensus meetings with R. E. Ready.
Many meetings were held and content themes were reﬁned
(added, deleted, expanded, narrowed) as appropriate until
a ﬁnal list was agreed upon: coping (attitudes about life,
approach to living, and behaviors, activities, and thoughts
related to living and that impact mental or physical health),
spirituality,interpersonalrelationships,HDinotherpersons,
employment, and other (e.g., personal symptoms of HD,
whichwererare,orvague/ambiguousstatementsthatdidnot
ﬁt into a more speciﬁc category).
2.2.2. Coding. Transcripts were broken down into codeable
units by the same three RAs. A codeable unit was deﬁned as a
complete thought and was usually a sentence; some complex
sentences were broken down into more than one codeable
unit.Eachunitwascodedalongthreedimensions:emotional
valence (positive, negative, other (mixed/neutral)), thematic
content (identiﬁed above), and time frame (present, past,
future, other).
Two independent RAs not previously involved in the
identiﬁcationofthematiccontentweretrainedonthe codingNeurology Research International 3
s y s t e m .T w oi n t e r v i e w s( o n ef r o map r o d r o m a lH Dp a r t i c i -
pant and one companion) were used for training purposes.
The RAs coded them independently and then, together,
reviewed ratings with R. E. Ready, and reconciled disagree-
ments to improve interrater reliability when scoring the
remaining interviews. Next, the remaining 13 interviews
were independently coded by each RA, followed by group
discussions with R. E. Ready, who served as the auditor,
to reconcile discrepancies and achieve consensus; kappa
agreement for each rating category was calculated prior to
consensus meetings.
2.3. Analyses. Analyses focused on frequency counts and
cross-tabulations of statements with regard to emotional
valence, themes, and time frame. Data from participants and
companionswereanalyzedseparately.Sincesomeprodromal
HD participants were part of a dyad (n = 6) and others
were not (n = 3), results are presented for all gene-
expanded participants (n = 9) as well as persons in dyads
(n = 6). Separating out the participants in dyads facilitates
comparison of participant and companion opinions about
QOL. Selected excerpts from interviews illustrate the main
ﬁndings. Lack of sum to 100% for results reported in tables
and in the text reﬂects that some statements were coded as
“other” (i.e., “other emotion,” “other time”).
3. Results
3.1. Interrater Reliability. Overall, coder agreement was fair
but variable (Table 1). Stronger rater agreement occurred
for easily identiﬁable content domains (i.e., employ-
ment, spirituality), emotional valence, and current behav-
iors/perceptions. Variability in coding was most notable for
statementsaboutthefuture,HDinotherpeople,andcoping.
Statements about the future were occasionally vague and
not always clearly linked to a time frame, which led to
inconsistency when determining if statements were about
the future or another time period. Coding statements about
HD in other people was also variable due to potential
overlap with the “interpersonal” category. To reduce overlap,
statements that referred to manifestations of HD in others or
witnessingHDinotherswerecodedas“HDinotherpeople,”
whereas interpersonal interactions with persons aﬀected
by HD were coded as “interpersonal.” Agreement about
statements related to coping were frequently ambiguous, but
coding was improved by only including statements related to
how persons were managing behaviors, thoughts, or feelings
in relation to their (or their partner’s) HD status.
It is a potential limitation that higher agreement could
not be achieved for some categories; however, all ﬁnal ratings
were made in consensus conferences and thus discrepancies
were resolved. Further, Hill et al. [15] cogently argue that in
qualitative, exploratory research, diﬀerences in opinion are
not necessarily a detriment to the process of discovery in the
early stages of a line of research.
3.2. Overall Frequencies. Statements about QOL were some-
what balanced between negativity and positivity (Table 1).
The present was mentioned more frequently that the past or
future. The most common content was related to interper-
sonal relationships and coping with HD status.
3.3. Emotion by Content Crosstabs. Examination of state-
ments by emotion and content indicated that statements
about employment were both positive and negative (Tables
2 and 3). For those in dyads, prodromal HD participants
tended to be more positive about employment, whereas
their companions exhibited more negativity. Prodromal HD
participants and companions exhibited similar and fairly
equalpositivityandnegativitywhendiscussinginterpersonal
relationships. Coping tended to be more positive than
negative for both groups.
Two content domains were highly valenced, meaning
that they had stronger emotions associated with them than
others. Spirituality was discussed in exclusively positive
terms, even though it was the most infrequent content
area. In contrast, HD in other people was more frequently
discussed in negative terms.
3.4. Valence by Time Frame Crosstabs. Statements about the
present were balanced somewhat more towards the positive
than negative, whereas statements about the future and past
were more often negative (Tables 4 and 5). It is perhaps
not surprising that gene-expanded persons make negative
statements about the future because it holds uncertainty
related to the manifestation of HD and coping with the
challenges of the disease. Negative statements about the
past often referred to diﬃcult decisions about undergoing
gene testing, initial reactions to being gene positive, and
interactions with family members around issues related to
HD.
3.5. Time Frame by Content Domain and Three-Way
Crosstabs. All content domains were well represented in
present-oriented statements (Table 6). Similar to Table 2,
spirituality and HD in others tended to be strongly positive
and negative, respectively. For prodromal HD participants,
comments about employment, interpersonal relationships,
and coping were weighted more towards the positive (52%,
53%,and63%,resp.)thanthenegative(25%,34%,and27%,
resp.). Similar to prodromal HD participants, employment,
interpersonal relationships, and coping were weighted more
towards the positive (48%, 56%, and 61%, resp.) than the
negative (12%, 14%, and 14%, resp.) for companions.
Future statements were not common, but, when they
were made by gene-expanded individuals, they pertained
most often to worries or concerns about maintaining
employment when symptoms of HD begin to manifest.
Furthermore, 91% of future statements by participants with
prodromal HD about employment were negative and none
were positive. When companions discussed the future, they
most often talked about HD in other people and inter-
personal relationships. For companions, more statements
were negative than positive for the future of interpersonal
relationships (63% versus 26%) and HD in others (80%
versus 10%).4 Neurology Research International
Table 1: Percentage of codeable statements and kappa agreement for content, time, and emotion codes.
All PrHD PrHD in Dyad Companions Range Mdn.
Valence
Negative emotion 38% 36% 39% 0.35–0.92 0.68
Positive emotion 41% 43% 38% 0.11–0.90 0.71
Time
Past 17% 17% 12% 0.38–0.76 0.52
Now 65% 66% 67% 0.00–0.84 0.72
Future 8% 7% 12% 0.20–0.67 0.48
Content
Employment 6% 6% 6% 0.50–1.00 0.70
Spirituality 2% 1% 4% 0.33–1.00 0.87
Interpersonal relationships 31% 32% 24% 0.54–0.77 0.60
HD in other people 10% 11% 8% 0.09–0.67 0.40
Coping 27% 29% 37% 0.13–0.60 0.44
N = 15 (9 persons prodromal for HD; 6 companions).
Table 2: Valence of QOL statements by content domain.
All PrHD PrHD in Dyad Companion
Positive Negative Positive Negative Positive Negative
Employment 38% 12% 51% 26% 37% 53%
Spirituality 83% 0% 85% 0% 56% 20%
Interpersonal relationships 43% 40% 40% 46% 43% 42%
HD in other people 6% 72% 8% 74% 8% 60%
Coping 55% 32% 51% 34% 56% 30%
PrHD: prodromal for HD. All PrHD N = 9; PrHD in study dyad N = 6; companion N = 6.
Table 3: Sample positive and negative QOL statements by content domain.
Positive statements PrHD Companion
Employment Well, one thing I did was change careers (to teaching). Teaching...would be more of a positive
experience.
Spirituality My faith has become stronger because I need that to
lean on.
She believes in God and lord as savior. She
believes that one day everything will be better.
Interpersonal
relationships I know my husband will take care of me. Well, she told me I’m a support system.
Coping Quality of life is to live life to the fullest and
experience most things that they can.
Good quality of life is ﬁnding satisfaction, I
suppose, in the things that you do.
Negative statements PrHD Companion
Employment I am not going to have a normal retirement age. I’m
concerned; I want to make sure I am ﬁnancially set. He works nine hour days.
Interpersonal
relationships
The emotional toll of being told (about being gene
positive) and then the ramiﬁcations for both yourself
and your family, is something that for me, at least,
sent me into a tailspin for a while.
The other thing that really aﬀects quality of life is
if you have children, that was ...probably the
hardest part for my husband, which is the fact we
had kids already and when we had children, he
had no idea he was at risk.
HD in other people
I have seen some pretty negative things with this
disease, as far as seeing people in my family who have
HD.
It makes it hard to relate or communicate with my
father-in-law because he is so negative or
depressed.
Coping I do worry about HD, I’ll admit that. We would both like to have more kids (but will
not due to HD).
PrHD: Prodromal for HD. Sample statements within each row are paired, such that they are taken from a single dyad.Neurology Research International 5
Table 4: Valence of QOL statements by time frame.
All PrHD PrHD in Dyad Companion
Positive Negative Positive Negative Positive Negative
Now 47% 35% 45% 38% 48% 31%
Future 27% 61% 27% 55% 31% 56%
Past 19% 53% 17% 51% 18% 61%
PrHD = Prodromal for HD. All PrHD N = 9; PrHD in study dyad N = 6; Companion N = 6.
Table 5: Sample positive and negative QOL statements by time frame.
Positive Statements PrHD Companion
Now
If you know (your gene status) you can start
planning your life accordingly, living every
moment.
Since you know that you have HD, you take
that into consideration and you intentionally
make decisions that are more impacting.
Future
I know it will be better for me than for my
father because I know my husband will
betaking care of me.
S h ek n o w st h a ts h ei sm a d es e c u r eb e c a u s es h e
is not going to be abandoned (in theFuture)
because of this.
Past My kids handled (results of gene testing) better
than most adults.
We went on a trip to (foreign country) and it
was totally awesome and I really feel like it was
a great memory for my family.
Negative Statements PrHD Companion
Now
My kids and my husband; they are very distant.
They don’t want to hear about it or learnabout
it.
I don’t think I have helped much.
Future The other thing that would make me sad
would be for (my kids) not to have their mom.
It can be hard to know that eventually, and
ultimately, you are going to get sick, so that
would probably be one of the hardest things,
just knowing.
Past My grandchild was born and I showed no
emotion.
Feeling guilty that maybe she passed on a gene
to one of her kids and then one of her
grandkids.
PrHD = Prodromal for HD. Sample statements within each row are paired, such that they are taken from a single dyad.
Statements about the past, while not common, tended
to be in reference to interpersonal relationships, HD in
others, and employment. For those with prodromal HD, past
statements about HD in others were 67% negative and 3%
positive; past statements about interpersonal relationships
were 58% negative and 20% positive; past statements about
employments were equally balanced positive (33%) and
negative (33%). For companions, all these content domains
tended to be more negative (56% for HD in others, 69%
for interpersonal relationships, 80% for employment) than
positive (0% for HD in others, 15% for interpersonal
relationships, 20% employment).
4. Discussion
Persons who are in the prodromal phase of HD and their
companions are focused predominantly on the “here and
now” rather than the past or the future. Thus, despite their
unique knowledge about the future, they see QOL as being
related to their present thoughts, activities, and behaviors.
The most common statements were about the importance of
a positive attitude. The importance of optimism came across
in a variety of ways, but participants were clearly focused on
living each moment to the fullest. Further, statements about
spirituality, while rare, were uniformly positive. Helping
persons with prodromal HD tap into or learn more about
spirituality may be an eﬀective means to increase life quality.
With regard to the present, respondents were slightly
more positive than negative. Relationships, employment,
and eﬀorts to cope with HD were discussed with a mix of
positivity and negativity, suggesting that these factors can
be assets and liabilities. The relative balance of positivity
and negativity in these common life domains may be a
hopeful sign for those in the prodromal phase of HD because
it suggests potential to “tip the balance” of experiences in
the positive direction; that is, if interpersonal relationships
are associated with complex emotions but have positive
attributes, it is theoretically possible to capitalize on the
positive aspects while helping persons cope with the less
adaptive aspects of their close relationships. In fact, eﬀorts
to capitalize on positive interpersonal perspectives have been
discussed in the cancer literature, with many suggesting
that interpersonal relationships can be actually improved
beyond their precancer level, even while patients report
concurrent interpersonal distress in their cancer experience
[16, 17]. Similar eﬀorts in prodromal HD populations may
be particularly helpful when working to improve QOL.6 Neurology Research International
Table 6: Time frame of QOL statements by content domain.
All PrHD PrHD in Dyad Companion
Now Future Past Now Future Past Now Future Past
Employment 58% 14% 19% 60% 13% 8% 66% 3% 26%
Spirituality 83% 4% 9% 92% 0% 8% 84% 8% 0%
Interpersonal relationships 67% 7% 21% 65% 7% 23% 66% 13% 18%
HD in other people 61% 3% 25% 59% 3% 24% 50% 19% 17%
Coping 75% 6% 10% 74% 6% 11% 77% 9% 9%
PrHD: Prodromal for HD. All PrHD N = 9; PrHD in study dyad N = 6; companion N = 6.
The most negative statements, not surprisingly, were
about witnessing HD in other people, most often a family
member. HD is a devastating disease that aﬀects inde-
pendence, movement, thinking, mood, and personality.
Witnessing the manifestations of HD in a loved one is
diﬃcult, and observing the psychiatric symptoms of HD
(e.g., depression, irritability, agitation, and aggression) can
be particularly stressful [18]. When participants discussed
negative reactions to observing HD in other persons, it
was usually in reference to past experiences, which partially
accounts for the negative valence surrounding statements
about the past.
These results suggest that interventions aimed at helping
people in the prodromal phase of HD cope with their reac-
tions to manifest HD in other persons may be particularly
helpful. Providing instrumental and emotional support in
coping with their past and current experiences with HD, in
fact, might be one of the best ways to improve QOL since
this issue was the biggest source of anxiety and distress in
discourse about QOL.
Although statements about past and present QOL
were largely similar between companions and their gene-
expanded partners, they diﬀered in their concerns about
the future. Persons with prodromal HD focused largely
on occupational functioning, probably because threats to
future employability are closely linked to income security
andavailabilityofhealthinsurance.Incontrast,companions’
future concerns were about interpersonal relationships and
HD in others. The companions’ focus on these domains
reﬂected concerns about the impact of progressing HD on
close relationships, as well as their own ability to cope with
uncertainty regarding their loved one’s health. In summary,
the worries of companions and prodromal HD individuals
were diﬀerent when looking to the future. These results
suggest that family interventions aimed at preparing for
future outcomes may be particularly helpful for improving
QOL.
4.1. Sample Limitations. Participants in this study were
unique. They pursued predictive genetic testing, whereas
most persons at risk for HD choose not to undergo testing,
indicating that participants in our sample may be more
mentally resilient than those in the general HD population
[8, 9]. Furthermore, many of them participate in research
as a means of coping and to make a positive contribution
to the future. Thus, they are motivated to know their own
risk for HD and to advance research about the disease. For
thesereasons,resultsofthisstudymaynotgeneralizetoother
persons in the prodromal phase of HD.
4.2. Conclusions and Future Directions. The current data
suggest that QOL in prodromal HD might be enhanced by
attending to spirituality, helping persons manage negative
responses to HD in others, and by taking steps to maximize
the positive and minimize the negative impacts of relation-
ships, employment, and coping strategies. Along these lines,
m o r ek n o w l e d g ea b o u tQ O Li np r o d r o m a lH Di sc r i t i c a lt o
help aﬀected persons, their families, and professionals learn
what it is like for healthy persons to live with the knowledge
that they are gene positive for HD. Attention to diﬀerential
future concerns from persons with prodromal HD and their
companions is warranted.
Since genetic testing was made available in 1993, testing
for HD has served as a model for other autosomal dominant
disorders such as early-onset familial AD [19]. There is scant
research on the psychological impact of genetic testing for
familial AD, but one small study suggests that persons at
risk for the disorder do not exhibit psychological symptoms
as they approach age of onset [20]. The current study in
prodromal HD sheds light on the importance of attending
more deeply to psychological issues and life quality in
persons at known or unknown risk for genetic disorders and
canserveasamodel forfutureworkinfamilialADandother
autosomal dominant disorders.
Appendix
Potential interview questions that were used to stimulate
discussion of quality of life (QOL) in presymptomatic Hunt-
ington’s Disease (HD). Not all questions were asked to all
persons or in the same way; they were adapted to each
interview as it progressed.
(1) What does QOL mean for a person who is at risk for
HD?
(a) Is QOL diﬀerent for persons who are not at risk
for HD? What about compared to persons who
already have the disease?
(b) Is QOL diﬀerent for a person who knows they are
genepositiveforHDversusapersonwhoisatrisk
but has an unknown gene status? How?Neurology Research International 7
(2) What are some important determinants or predictors of
QOL in persons at risk for HD?
(a) What factors might increase QOL?
(b) Decrease QOL?
(3) How does knowledge about your future risk for HD
impact your QOL right now?
(a) Does worry about the future aﬀect your QOL?
How so?
(b) What about feelings of guilt?
(c) Doesbeingsecretiveversusopenaboutgenestatus
aﬀect QOL?
(d) Do you have coping strategies that improve your
QOL?
(4) Are there any beneﬁts to QOL in knowing your gene
status? Any drawbacks?
(5) Are there ways that QOL can be maximized for persons
at risk for HD? How?
(6) Are there certain persons, situations, or stressors that
are particularly detrimental to QOL for persons at risk
for HD?
Acknowledgments
This research is supported by the National Institutes of
Health, National Institute of Neurological Disorders and
Stroke (NS040068), and CHDI Foundation.
References
[1] F. O. Walker, “Huntington’s disease,” The Lancet, vol. 369, pp.
218–228, 2007.
[2] D. I. Helder, A. A. Kaptein, G. M. J. van Kempen, J.
Weinman, H. C. van Houwelingen, and R. A. C. Roos,
“Living with Huntington’s disease: illness perceptions, coping
mechanisms and patients’ well-being,” The British Journal of
Health Psychology, vol. 7, no. 4, pp. 449–462, 2002.
[ 3 ]A .K .H o ,A .O .G .R o b b i n s ,S .J .W a l t e r s ,S .K a p t o g e ,B .
J. Sahakian, and R. A. Barker, “Health-related quality of
life in Huntington’s disease: a comparison of two generic
instruments,” Movement Disorders, vol. 19, no. 11, pp. 1341–
1348, 2004.
[4] R. E. Ready, M. Mathews, A. Leserman, and J. S. Paulsen,
“Patient and caregiver quality of life in Huntington’s disease,”
Movement Disorders, vol. 23, no. 5, pp. 721–726, 2008.
[5] Huntington’s Disease Collaborative Research Group, “A novel
gene containing a trinucleotide repeat that is expanded and
unstable on Huntington’s disease chromosomes,” Cell, vol. 72,
pp. 971–983, 1993.
[6] S. D. Taylor, “Predictive genetic test decisions for Huntington’s
disease: context, appraisal and new moral imperatives,” Social
Science and Medicine, vol. 58, no. 1, pp. 137–149, 2004.
[7] R. Klitzman, D. Thorne, J. Williamson, W. Chung, and K.
Marder, “Decision-making about reproductive choices among
individualsat-riskforHuntington’sdisease,”JournalofGenetic
Counseling, vol. 16, no. 3, pp. 347–362, 2007.
[8] A. Tibben, “Predictive testing for Huntington’s disease,” Brain
Research Bulletin, vol. 72, no. 2-3, pp. 165–171, 2007.
[9] G. Evers-Kiebooms and M. Decruyenaere, “Predictive testing
for Huntington’s disease: a challenge for persons at risk and
for professionals,” Patient Education and Counseling, vol. 35,
no. 1, pp. 15–26, 1998.
[10] A. M. Codori and J. Brandt, “Psychological costs and beneﬁts
of predictive testing for Huntington’s disease,” The American
Journal of Medical Genetics, vol. 54, no. 3, pp. 174–184, 1994.
[11] M. Bloch, S. Adam, S. Wiggins, M. Huggins, and M. R.
Hayden, “Predictive testing for Huntington disease in Canada:
the experience of those receiving an increased risk,” The
American Journal of Medical Genetics, vol. 42, no. 4, pp. 499–
507, 1992.
[ 1 2 ]A .M .C o d o r i ,P .R .S l a v n e y ,C .Y o u n g ,D .L .M i g l i o r e t t i ,a n d
J. Brandt, “Predictors of psychological adjustment to genetic
testing for Huntington’s disease,” Health Psychology, vol. 16,
no. 1, pp. 36–50, 1997.
[13] T. B. Robins Wahlin, L. Backman, A. Lundin, A. Haegermark,
B. Winblad, and M. Anvret, “High suicidal ideation in
persons testing for Huntington’s disease,” Acta Neurologica
Scandinavica, vol. 102, no. 3, pp. 150–161, 2000.
[14] Federal Drug Administration, “Guidance for industry patient-
reported outcome measures:use in medical product develop-
ment to support labeling claims”.
[ 1 5 ]C .E .H i l l ,B .J .T h o m p s o n ,a n dE .N .W i l l i a m s ,“ Ag u i d e
to conducting consensual qualitative research,” Counseling
Psychologist, vol. 25, no. 4, pp. 517–572, 1997.
[16] M. Cordova, “Facilitating posttraumatic growth following
cancer,”inTrauma,RecoveryandGrowth:PositivePsychological
Perspectives on Posttraumatic Stress, S. Joseph and P. A. Linley,
Eds., pp. 185–206, John Wiley & Sons, Hoboken, NJ, USA,
2008.
[17] M. J. Cordova, L. L. Cunningham, C. R. Carlson, and M. A.
Andrykowski, “Posttraumatic growth following breast cancer:
a controlled comparison study,” Health Psychology, vol. 20, no.
3, pp. 176–185, 2001.
[18] J. S. Paulsen, R. E. Ready, J. M. Hamilton, M. S. Mega, and
J. L. Cummings, “Neuropsychiatric aspects of Huntington’s
disease,” Journal of Neurology, Neurosurgery and Psychiatry,
vol. 71, no. 3, pp. 310–314, 2001.
[19] W. Meschino and A. Lennox, “Workshop report: genetic
testing programs for familial Alzheimer’s disease,” Alzheimer
Disease and Associated Disorders, vol. 8, no. 2, pp. 68–70, 1994.
[20] J. M. Swearer, B. F. O’Donnell, M. Parker, K. J. Kane, and
D. A. Drachman, “Psychological features in persons at risk
for familial Alzheimer’s disease,” The American Journal of
Alzheimer’s Disease and Other Dementias,v o l .1 6 ,n o .3 ,p p .
157–162, 2001.